Form 8-K - Current report:
SEC Accession No. 0001023024-07-000024
Filing Date
2007-11-13
Accepted
2007-11-13 16:42:53
Documents
3
Period of Report
2007-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 2007 Q3 8K biosante8kforq32007.htm 8-K 25789
2 PRESS RELEASE pressrelease.htm EX-99.1 11097
3 LOGO biosantelogo6.jpg GRAPHIC 13169
  Complete submission text file 0001023024-07-000024.txt   56822
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 071238826
SIC: 2836 Biological Products, (No Diagnostic Substances)